Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation…
By B. Maron, J. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A. Moss, C. Seidman, James B. Young. Circulation, 2006
3,055 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/ef66d43779cc8e6c050f841229be9dcc0cb2552f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- G. Fonarow
- S. Anker
- T. Horwich
- C. Semsarian
- Gerasimos Filippatos
- J. Januzzi
- J. Towbin
- Douglas P. Zipes
Citations in the corpus
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡ (2008, neutral): “The American Heart Association has issued a scientific statement.(42) Both take into account the great advances made recently in understanding the genetic origins and the biology of the cardiomyopathies.”
- Universal Definition and Classification of Heart Failure. (2021, background): “Even guideline statements from various scientific bodies have varied in their use of this term.(25,26) Furthermore, the maladaptive hemodynamic and compensatory mechanisms in HF may result in development of or worsening of cardiomyopathy.”
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. (2019, background): “This decision was largely based on data regarding the role of pathologic variants in genes encoding defective ion channel proteins, governing cell membrane transit of sodium, potassium, and calcium ions leading to ion channel-related arrhythmia disorders, including LQTS, SQTS, BrS, and CPVT and the ”
- The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. (2007, background): “HCM occurs in an autosomal dominant pattern in 1:500 of the general population recognized to have the clinical phenotype (122), which makes it the most frequently occurring cardiomyopathy.”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “opathies, a new classification scheme based on genomics was proposed in 2006.(23) We recognize that classification of car-”